BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24031455)

  • 1. Vaginal lactobacilli as potential probiotics against Candida SPP.
    Gil NF; Martinez RC; Gomes BC; Nomizo A; De Martinis EC
    Braz J Microbiol; 2010 Jan; 41(1):6-14. PubMed ID: 24031455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of probiotic properties in human vaginal lactobacilli strains.
    Hütt P; Lapp E; Štšepetova J; Smidt I; Taelma H; Borovkova N; Oopkaup H; Ahelik A; Rööp T; Hoidmets D; Samuel K; Salumets A; Mändar R
    Microb Ecol Health Dis; 2016; 27():30484. PubMed ID: 27527701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.
    Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M
    Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Potential Probiotic Lactobacilli for Prevention and Treatment of Vulvovaginal Infections.
    Kumherová M; Veselá K; Kosová M; Mašata J; Horáčková Š; Šmidrkal J
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):163-172. PubMed ID: 32583131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
    Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
    PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability.
    Zakaria Gomaa E
    J Gen Appl Microbiol; 2013; 59(6):425-36. PubMed ID: 24492601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate.
    Ahire JJ; Sahoo S; Kashikar MS; Heerekar A; Lakshmi SG; Madempudi RS
    Probiotics Antimicrob Proteins; 2023 Apr; 15(2):275-286. PubMed ID: 34417721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic and Metabolic Characterization of Vaginal Lactobacilli for a Potential Use in Functional Foods.
    D'Alessandro M; Parolin C; Bukvicki D; Siroli L; Vitali B; De Angelis M; Lanciotti R; Patrignani F
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33919838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus for Vaginal Microflora Correction.
    Saduakhasova S; Kushugulova A; Shakhabayeva G; Kozhakhmetov S; Khasenbekova Z; Tynybayeva I; Nurgozhin T; Zhumadilov Z
    Cent Asian J Glob Health; 2014; 3(Suppl):171. PubMed ID: 29805900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
    De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
    Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the therapeutic potentials of
    ElFeky DS; Awad AR; Shamseldeen AM; Mowafy HL; Hosny SA
    Front Microbiol; 2023; 14():1222503. PubMed ID: 37529322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and physicochemical properties of biosurfactants produced by Lactobacillus jensenii P
    Morais IMC; Cordeiro AL; Teixeira GS; Domingues VS; Nardi RMD; Monteiro AS; Alves RJ; Siqueira EP; Santos VL
    Microb Cell Fact; 2017 Sep; 16(1):155. PubMed ID: 28927409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic
    Jørgensen MR; Kragelund C; Jensen PØ; Keller MK; Twetman S
    J Oral Microbiol; 2017; 9(1):1274582. PubMed ID: 28326154
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility to some antifungal drugs of vaginal lactobacilli isolated from healthy women.
    Kilic E; Aslim B; Taner Z
    Drug Metabol Drug Interact; 2005; 21(1):67-74. PubMed ID: 16086557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory activity of vaginal Lactobacillus bacteria on yeasts causing vulvovaginal candidiasis].
    Strus M; Brzychczy-Włoch M; Kucharska A; Gosiewski T; Heczko PB
    Med Dosw Mikrobiol; 2005; 57(1):7-17. PubMed ID: 16130291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Compounds Produced by Vaginal
    Wang S; Wang Q; Yang E; Yan L; Li T; Zhuang H
    Front Microbiol; 2017; 8():564. PubMed ID: 28421058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal lactobacilli: self- and co-aggregating ability.
    Ocaña VS; Nader-Macías ME
    Br J Biomed Sci; 2002; 59(4):183-90. PubMed ID: 12572950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of culture conditions on co-aggregation of probiotic yeast Saccharomyces boulardii with Candida spp. and their auto-aggregation.
    Tomičić R; Tomičić Z; Raspor P
    Folia Microbiol (Praha); 2022 Jun; 67(3):507-515. PubMed ID: 35169980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross sectional analysis of vaginal Lactobacillus in asymptomatic women of reproductive age in Mumbai, India.
    Pramanick R; Parab S; Mayadeo N; Warke H; Aranha C
    J Infect Dev Ctries; 2018 Dec; 12(12):1096-1104. PubMed ID: 32027611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
    Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
    PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.